Holen Sie sich die Stockscreener-App
30.30
0.98%
-0.30
Handel nachbörslich:
30.25
-0.05
-0.17%
Schlusskurs vom Vortag:
$30.60
Offen:
$30.36
24-Stunden-Volumen:
142.00K
Relative Volume:
2.33
Marktkapitalisierung:
$450.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+44.84%
1M Leistung:
+57.81%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$29.04
$30.94
1-Wochen-Bereich:
$20.90
$31.66
52-Wochen-Spanne:
$15.00
$31.66
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com UK
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Farallon Capital Management LLC Makes New $7.10 Million Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Farallon Capital Management LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com Canada
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - MarketBeat
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com India
Tectonic reports positive Phase 1a results for heart treatment TX45 By Investing.com - Investing.com Australia
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Yahoo Finance
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High at $19.88 - MarketBeat
Tectonic Therapeutic’s TX45 Shows Promise in Phase 1a Trial - TipRanks
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9% - MarketBeat
Atlas Venture Life Science Advisors LLC Purchases New Stake in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 52.6% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $17.50 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 2.9% - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 50.4% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Growth in Short Interest - Defense World
AVROBIO, Inc. announced that it has received $25.150002 million in funding from Atlas Venture L.P., SV Health Investors, LLC, Blackstone Life Sciences - Marketscreener.com
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024 - InvestorPlace
Contrasting SpringWorks Therapeutics (NASDAQ:SWTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $16.25 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Tectonic stock wins bullish view at Wells Fargo (NASDAQ:TECX) - Seeking Alpha
Wells Fargo rates Tectonic Therapeutics shares Overweight, cites TX45's potential - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Research Coverage Started at Wells Fargo & Company - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Stock Quotes, Forecast and News Summary - Benzinga
Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewswire
Tectonic Therapeutic to Participate in September Investor Conferences - StockTitan
Tectonic Therapeutic to Participate in September Investor Conferences - Yahoo Finance
Q3 2024 Earnings Estimate for Tectonic Therapeutic Issued By Leerink Partnrs (NASDAQ:TECX) - MarketBeat
Leerink Partnrs Brokers Reduce Earnings Estimates for Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Strong Trading Volume - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 4.6% - MarketBeat
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan
Head to Head Contrast: Tectonic Therapeutic (TECX) & Its Competitors - Defense World
Reviewing VectivBio (NASDAQ:VECT) & Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):